EN DE

Marex Group (MRX) Fair Value & Analysis

Financial Services · US · Market cap $4.7B

MG Marex Group logo Marex Group MRX · US
Price$60.81
Fair Value$24.60
Upside-59.6%
Quality52/100
Watch Marex Group for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 10.6% net margin
High debt · generates free cash flow
0.91% dividend yield
Trails peers (5/14)
Moderate moat 58/100
Evidence: High Range $18.45 – $30.75 Share as image

Fair value as of: Jul 16, 2026

From 13 valuation models · updated 24 days ago

Share price −9.5% over the past month.

A solid business, but screening 60% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($30.75). The favourable scenario is already priced in.
  • Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (2 years)

$70.29 $18.09 Fair Value $24.60 Apr 2024 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

27‑month range $18.09 – $70.29 · fair‑value band $18.45 – $30.75 · the $60.81 price screens above the $24.60 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Marex Group (MRX) currently trades at $60.81, while our model-based Fair Value estimate is $24.60, implying the stock looks roughly 59.6% overvalued today. The Quality Score stands at 52/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Marex Group generated revenue of $3.3B at a net margin of 10.6%. Revenue grew 55.1% year over year. It earns a return on equity of 29.1%. Net debt stands at $3.8B. Fundamentals as of Jul 16, 2026

Our scenario range runs from $18.45 (bear case) to $30.75 (bull case); at $60.81, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 120% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 11% fair-value upside, at -60%, MRX screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $192.20 $300.60 $512.75 80
Residual Income $28.43 $39.80 $245.95 76
Rev-Margin DCF $158.94 $241.35 $405.19 74
All 13 models by family
DCF Models
Owner Earnings $124.68 $207.83 $375.98 31
5Y P/E Exit $128.52 $192.04 $274.23 38
10Y P/E Exit $151.47 $229.04 $346.49 35
Earnings-Based
Graham-Dodd $29.14 $203.19 $285.14 54
Lynch FV $89.05 $127.21 $165.38 50
Dividend Discount
Gordon GGM $6.78 $13.50 $20.45 70
DDM Multi-Stage $6.78 $11.67 $14.25 61
Multiples
P/E Multiple $41.78 $55.70 $69.63 63
P/B Multiple $18.45 $24.60 $30.75 55
Asset-Based
NCAV (Graham) $8.78 $11.77 $17.57 50
Growth DCF
Growth DCF $192.20 $300.60 $512.75 80
Rev-Margin DCF $158.94 $241.35 $405.19 74
Economic Profit
Residual Income $28.43 $39.80 $245.95 76

Widest divergence: Growth DCF ($241.35) versus Dividend Discount ($11.67). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $3.3B
Revenue growth (YoY) +55.1%
Net margin 10.6%
Return on equity 29.1%
Free cash flow $654M FY2025
P/E ratio 14.9
More key figures
Operating margin 13.1%
EPS (TTM) $4.37
Dividend yield 0.9%
EPS growth (YoY) +55.4%
Net debt $3.8B FY2025

Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 52/100

Of which business quality 60 · Market factors (momentum, volatility) 83

Profitability 33
Margins and returns on capital today
Quality Growth 75
Are margins and returns improving?
Cashflow 86
Earnings quality: real cash, not paper profit
Fin. Strength 61
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 89
Price trend over the last 3–12 months (market factor)
52W Momentum 88
Distance to the 52-week high (market factor)
Net Issuance 64
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Marex Group plc, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments.

Full company description

Marex Group plc, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and fixed income, financial securities, digital assets, and equity futures and options; liquidity, execution, and risk management solutions to financial markets. It also provides liquidity to clients in the OTC energy markets; market data, analytics, and market commentary; energy services, including gas, power, environmental, and crude oil markets; and market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across a spectrum of markets, including agriculture, currency, and interest rate markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates; and a portfolio of structured Notes, including auto-callable, fixed, stability, and credit-linked notes. Additionally, the company offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. Marex Group plc was incorporated in 2005 and is based in London, the United Kingdom.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Marex Group reported revenue of $3.6B in FY2025 versus $852M in FY2021, a compound +43.7%/yr. Reported net income was $308M in FY2025, compounding +52.8%/yr from FY2021.

Growth Quality 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$3.6B
Latest YoY
+25.4%
Avg. growth/yr (3Y)
+45.6%
Avg. growth/yr (5Y)
+36.8%
Avg. growth/yr (12Y)
+21.3%
Revenue +43.7%/yr
FY21 $852M
FY22 $1.2B
FY23 $2.4B
FY24 $2.9B
FY25 $3.6B
Net income +52.8%/yr
FY21 $56.5M
FY22 $91.6M
FY23 $128M
FY24 $218M
FY25 $308M

MRX screens 60% overvalued. Compare with Huatai Securities Co →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Marex Group Fair Value". https://www.fairvalue-calculator.com/stock/MRX

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Capital Markets · 425 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 60 · Above median
Fair Value upside −60% · Bottom 25%
Return on equity (TTM) 29% · Top 25%
Return on assets 1% · Below median
Net margin (TTM) 11% · Below median
Operating margin (TTM) 13% · Below median
Revenue growth 55% · Above median
Dividend yield (TTM) 0.9% · Below median
Debt / equity 1.84× · Higher than 75% of peers

Valuation Multiples vs Capital Markets median · lower = cheaper

P/E (TTM) 14.9× · Pricier than median
P/B 3.70× · Pricier than 75% of peers
P/S (TTM) 1.43× · Cheaper than median
P/FCF 7.2× · Pricier than median
EV/EBITDA 0.5× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 9
FUTURE 100 · sector 96
PAST 100 · sector 30
HEALTH 8 · sector 93
DIVIDEND 18 · sector 36

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Capital Markets stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Huatai Securities Co HTSC $0.2700 $0.0400 -85%
Mirae Asset Securities Co 006800 38,750 KRW 31,645 KRW -18%
Meritz Financial Group 138040 117,000 KRW 87,706 KRW -25%
Korea Investment Holdings 071050 239,000 KRW 318,825 KRW +33%
NH Investment & Securities Co 005940 31,000 KRW 37,133 KRW +20%
Samsung Securities Co 016360 107,700 KRW 126,487 KRW +17%
Motilal Oswal Financial Services Limited MOTILALOFS ₹967.00 ₹299.65 -69%
Kiwoom Securities Co 039490 322,000 KRW 358,091 KRW +11%
SSI Securities Corporation SSI 24,250 VND 28,021 VND +16%
Bolsas y Mercados Argentinos S.A BYMA 313.75 ARS 120.22 ARS -62%

Compare Marex Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Marex Group (MRX) overvalued or undervalued?
As of Jul 16, 2026, our model estimates a fair value of $24.60 versus a price of $60.81, about −60% (overvalued).
What is the fair value of MRX?
Our model-based fair value for Marex Group is $24.60 (as of Jul 16, 2026), built from audited fundamentals. The current price is $60.81.
What is the quality score of MRX?
Marex Group has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Marex Group (MRX)?
Marex Group reported trailing-twelve-month revenue of about $3.3B (latest available figure, as of Jul 16, 2026).
What is the net profit margin of MRX?
The net profit margin of Marex Group is about 10.6%, meaning it keeps roughly 10.6% of revenue as net income. Based on the latest reported figures.
Does Marex Group pay a dividend?
Marex Group currently shows a dividend yield of about 1.12% relative to its recent price (as of Jul 16, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Marex Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.